Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.
about
Tumor angiogenesis: pericytes and maturation are not to be ignoredBreast Cancer-Associated Fibroblasts: Where We Are and Where We Need to GoThe microenvironment in breast cancer progression: biology and implications for treatmentRecent developments in myofibroblast biology: paradigms for connective tissue remodelingTumor stroma as targets for cancer therapyWhy don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionLeukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyPlatelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.Phase II open-label study of sunitinib in patients with advanced breast cancer.Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.Anti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential.Role of receptor tyrosine kinases and their ligands in glioblastoma.Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cellsTwist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells.Peptide-based targeting of the platelet-derived growth factor receptor beta.Targeting the PDGF signaling pathway in tumor treatmentPDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer.Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.Stromal LRP1 in lung adenocarcinoma predicts clinical outcome.Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization.A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium.Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell CarcinomaFibroblasts--a key host cell type in tumor initiation, progression, and metastasis.PDGFRβ Is a Novel Marker of Stromal Activation in Oral Squamous Cell CarcinomasSunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial.Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.Immunohistochemical expression of platelet-derived growth factor receptors in ovarian cancer patients with long-term follow-up.Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinibQuantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancerTumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness.Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells.VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma.Emerging therapeutic targets in metastatic progression: A focus on breast cancer.Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.
P2860
Q21296683-01A14CDA-39AD-4A49-9228-4974CD983C9DQ26772925-B002A828-CE04-49D0-BB07-910FA5456E9FQ26851314-944F86B8-0F83-4F3A-AAD6-9853D7339E8BQ26863751-035DEE34-B56A-4363-9CD0-7A6DB39B42ABQ27015980-65F3340A-145B-49A0-A273-96084208CB2AQ29614274-DF9AFDDE-A148-4D22-A5B8-775B0E3F9607Q29618033-2FAE9B84-387F-4DD2-8AD8-E3046C76278FQ30250273-5C1EA435-0A3A-4B6E-ADA9-03748A7D26A3Q33403848-B2F3FD82-EC94-4B6B-8AE4-579B1A8169C8Q33588577-CFCF5849-0136-49D1-8FA2-2F1B5970E5A5Q33651783-C609EC42-5744-4835-BDEE-79C789E3F14BQ33726477-DA2647FA-EE7B-4ED5-8799-A606E3AC9149Q33755480-7F5C1B0D-1B8F-498D-AFED-6F7CCEF3D175Q33794403-34785DFC-D9ED-4176-B40E-C2D695BD1055Q33829335-73C1B36A-9671-4BA1-9197-567D608060ACQ33883849-9AD23E4E-CB87-4981-A6B2-C8394E266568Q33916413-FCEE9D05-960D-443D-AE6D-98BC1807098DQ33997938-03EB2122-A552-4045-BD5F-A779FF1E6A57Q34140712-90BC135B-6625-48C3-BA1C-531A0D3B1212Q34335171-E96E2ADD-6547-4F97-8177-516B26DD5E21Q34393461-450EA91E-3C05-48E4-872B-9E68B5D6DD89Q34475004-E8D6E339-D245-4801-83E7-13D4A21CA906Q34634642-E9935790-7EEA-4C1F-9263-CCD4DA3E2FD0Q34801160-C557E353-7985-4B4E-B180-702E7A038A22Q34810329-92B3BCF3-CEEF-42DA-8AE6-DA089F0AF4EFQ35136732-56A71AD2-C9E6-4AE8-B4A3-F86339EC3D84Q35584239-1B762BB7-4395-4A19-BBFB-783E79DC85AEQ35885691-F0DEE723-CE36-4ABA-AA3B-26D51048FAF6Q35920503-48AF2C6C-92D8-41D8-B634-FCAF52EF02BAQ36003190-55680132-1F6B-4040-9C36-EAD849DAF0A9Q36197026-E5C1950D-A82F-4701-800F-3E6F4E560EB0Q36245376-233AB06E-7622-40AD-9E8D-357F1BA48E91Q36289382-5E75982D-D40A-4D9F-B7F7-40EE5F12C79BQ36402874-70A3CD00-2388-4BB3-A7F4-4CD2A5AE0BD9Q36432378-180681D0-FD2A-48B1-BD21-5B41226B6E72Q36527927-3F32474A-E695-416F-B1CA-AC22CD781CB6Q36678970-C27FB3C8-980B-475A-A01F-E422485BC8DCQ36832127-858049D2-0D07-40CD-8FEA-1D4DD7E5F241Q36854062-5CF1A24D-95C7-4CEC-B9DC-D3142313F0CEQ36903863-52D8FE6D-8803-466F-8E14-56893E25255F
P2860
Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic significance of str ...... ession in human breast cancer.
@en
Prognostic significance of str ...... ession in human breast cancer.
@nl
type
label
Prognostic significance of str ...... ession in human breast cancer.
@en
Prognostic significance of str ...... ession in human breast cancer.
@nl
prefLabel
Prognostic significance of str ...... ession in human breast cancer.
@en
Prognostic significance of str ...... ession in human breast cancer.
@nl
P2093
P2860
P1476
Prognostic significance of str ...... ession in human breast cancer.
@en
P2093
Arne Ostman
Carl-Henrik Heldin
Donal J Brennan
Göran Landberg
Janna Paulsson
Jonas Bergh
Patrick Micke
Tobias Sjöblom
P2860
P304
P356
10.2353/AJPATH.2009.081030
P407
P577
2009-06-04T00:00:00Z